TMDX

Transmedics Group Stock Analysis

AI Rating

Good
  • Quality8/10
  • Growth 9/10
  • Value 2/10
Transmedics Group sales and earnings growth
TMDX Growth
Great
  • Revenue Y/Y 37.13%
  • EPS Y/Y 423.36%
  • FCF Y/Y 265.04%
Transmedics Group gross and profit margin trends
TMDX Profitability
Great
  • Gross margin 59.90%
  • EPS margin 31.40%
  • ROIC 5Y 1.53%
Transmedics Group net debt vs free cash flow
TMDX Risk
Good
  • Debt / Equity 1.1
  • Debt / FCF 0.2
  • Interest coverage 8.8

Transmedics Group stock volatility is in-line with the overall market. We give it a Good risk rating.

More Medical Devices stocks ↗